Anon. (1993). A Strategy for the Assessment of the Reproductive Toxicity of New Substances: Risk Assessment of Notified New Substances (Directive 93/67/EEC). Technical Guidance Document, Chapter 8, 14 pp. Brussels: European Commission (DGXI).
3.
Anon. (1993). OECD Guidelines for the Testing of Chemicals, Draft Guideline 421: Reproduction/Developmental Toxicity Screening Test, 8 pp. Paris: OECD.
4.
Anon. (1993). OECD Guidelines for the Testing of Chemicals, Draft Guideline 422: Combined Repeated Dose Toxicity Study with the Reproduction/Developmental Toxicity Screening Test, 8 pp. Paris: OECD.
5.
VilleneuveD.C., & KoëterH.B.W.M. eds (1993). Proceedings of the International Workshop on In Vitro Methods in Reproductive Toxicology.Reproductive Toxicology7, Suppl. 1. 1–175.
6.
Anon. (1983). OECD Guidelines for Testing of Chemicals, No. 415 (One-Generation Reproduction Toxicity Study, 8 pp.) and No. 416 (Two-Generation Reproduction Toxicity Study, 8 pp.). Paris: OECD.
7.
MattisonD.R. (1993). Sites of female reproductive vulnerability: implications for testing and risk assessment.Reproductive Toxicology7, Suppl. 1, 53–62.
8.
HollowayA.J., MooreH.D.M., and FosterP.M.D. (1990). The use of in vitro fertilisation to detect reductions in fertility of male rats exposed to 1,3–dinitrobenzene.Fundamental and Applied Toxicology14, 113–122.
9.
SpielmannH., and VogelR. (1989). Unique role of studies on preimplantation embryos to understand mechanisms of embryotoxicity in early pregnancy.Critical Reviews in Toxicology20, 51–64.
10.
MorrisseyR.E., SchwetzB.A., LambJ.C., RossM.D., TeagueJ.L., and MorrisR.W. (1988). Evaluation of rodent sperm, vaginal cytology and reproductive organ weight from NTP 13-week studies.Fundamental and Applied Toxicology11, 343–358.
11.
EvensonD.P., BaerR.K., and JostL.K. (1989). Long-term effects of triethylene-melamine exposure on mouse testis cells and sperm chromatin structure assayed by flow cytometry.Environmental and Molecular Mutagenesis14, 79–89.
12.
UlbrichB., and PalmerA.K. (1995). Detection of effects on male reproduction: a literature survey.Journal of the American College of Toxicology14, 293–327.
13.
EvensonD.P. (1986). Flow cytometry of acridine orange stained sperm is a rapid and practical method for monitoring occupational exposure to genotoxicants. In Monitoring of Occupational Genotoxicants (ed. SorsaM., NorppaH.), pp. 121–132. New York: Alan R. Liss.
14.
EvensonD.P., HigginsP.H., GruenebergD., and BallacheyD.E. (1985). Flow cytometric analysis of mouse spermatogenic function following exposure to ethylnitrosourea.Cytometry6, 238–253.
15.
BallsM., BlaauboerB.J., FentemJ.H., BrunerL., CombesR.D., EkwallB., FielderR.J., GuillouzoA., LewisR.W., LovellD.P., ReinhardtC.A., RepettoG., SladowskiD., SpielmannH., and ZuccoF. (1995). Practical aspects of the validation of toxicity test procedures. The report and recommendations of ECVAM workshop 5.ATLA23, 129–147.
16.
PrattR.M., GroveR.I., and WillisW.D. (1982). Prescreening for environmental teratogens using cultured mesenchymal cells from the human embryonic palate.Teratogenesis, Carcinogenesis and Mutagenesis2, 313–318.
17.
BraunA.G., NichinsonB.B., and HorowiczP.B. (1982). Inhibition of tumour cell attachment to concanavalin A-coated surfaces as an assay for teratogenic agents: approaches to validation.Teratogenesis, Carcinogenesis and Mutagenesis2, 343–354.
18.
MummeryC.L., van der BrinkC.E., van der SaagP.T., & De LaatS.W. (1984). A short-term screening test for teratogens using differentiating neuroblastoma cells in vitro.Teratology29, 271–279.
19.
SteeleV.E., MorrisseyR.E., ElmoreE.L., Gurganus-RochaD., WilkinsonB.P., CurrenR.D., SchmetterB.S., LouieA.T., LambJ.C., and YangL.I.L. (1988). Evaluation of two in vitro assays to screen for potential development toxicants.Fundamental and Applied Toxicology11, 673–684.
20.
RohwedelJ., MaltsevV., BoberE., ArnoldH.H., HeschelerJ., and WobusA.M. (1994). Muscle cell differentiation of embryonic stem cells reflects myogenesis in vivo: developmental^ regulated expression of myogenic determination genes and functional expression of ionic currents.Developmental Biology164, 87–101.
21.
HeuerJ., GraeberI.M., PohlI., and SpielmannH. (1994). An in vitro embryotoxicity assay using the differentiation of embryonic mouse stem cells into haematopoietic cells.Toxicology in Vitro8, 585–587.
22.
LaschinskiG., VogelR., and SpielmannH. (1991). Cytotoxicity test using blastocyst-derived euploid embryonal stem cells: a new approach to in vitro teratogenesis screening.Reproductive Toxicology5, 57–64.
23.
NewallD.R., and BeedlesK.E. (1994). The stem-cell test: a novel in vitro assay for teratogenic potential.Toxicology in Vitro8, 697–701.
24.
HoogheR.J., and OomsD. (1995). Use of the fluorescence-activated cell sorter (FACS) for in vitro assays of developmental toxicity.Toxicology in Vitro9, 349–354.
25.
UmanskyR. (1966). The effect of cell population density on the developmental fate of reaggregating mouse limb bud mesenchyme.Developmental Biology13, 31–56.
26.
FlintO.P. (1983). A micromass culture method for rat embryonic neural cells.Journal of Cell Science61, 247–262.
27.
FlintO.P., and OrtonT.C. (1984). An in vitro assay for teratogens with cultures of rat embryo midbrain and limb cells.Toxicology and Applied Pharmacology76, 383–395.
28.
FlintO.P. (1993). In vitro tests for teratogens: desirable endpoints, test batteries and current status of the micromass teratogen test.Reproductive Toxicology7, Suppl. 1, 103–111.
29.
BrownN.A., and WigerR. (1992). A comparison of rat and chick limb bud micromass cultures for developmental toxicity screening.Toxicology in Vitro6, 101–108.
30.
RenaultJ-Y., MelcionC., and CordierA. (1989). Limb bud cell culture for in vitro teratogen screening: validation of an improved assessment method using 51 compounds.Teratogenicity, Carcinogenicity and Mutagenicity9, 83–96.
31.
FlintO.P., OrtonT.C., and FergusonR.A. (1984). Differentiation of rat embryo cells in culture: response following acute maternal exposure to teratogens and non-teratogens.Journal of Applied Toxicology4, 109–116.
32.
KistlerA., TsuchiyaT., TsuchiyaM., and KlausM. (1990). Teratogenicity of arotinoids (retinoids) in vivo and in vitro.Archives of Toxicology64, 616–622.
33.
FlintO.P., and BoyleF.T. (1986). Structure-teratogenicity relationships among antifungal triazoles. In Handbook of Experimental Pharmacology, Volume 96, Chemotherapy of Fungal Disease (ed. RyleyJ.F.), pp. 231–249. Berlin: Springer-Verlag.
34.
TsuchiyaT., TakahashiA., AsadaS., TakakuboF., Ohsumi-YamashitaN., and EtoK. (1991). Comparative study of embryotoxic action of ethylenethiourea in rat whole-embryo and embryonic cell culture.Teratology43, 319–324.
35.
TsuchiyaT., NakamuraA., IioT., and TakahashiA. (1991). Species differences between rats and mice in the teratogenic action of ethylenethiourea: in vivo/in vitro tests and teratogenic activity of sera using an embryonic cell differentiation system.Toxicology and Applied Pharmacology109, 1–6.
36.
NewallD.R. (1990). Strain differences in the response of embryonic cells to teratogens as determined in vitro using the micromass test.Teratology42, 28A.
37.
BrownL.P., FosterJ.R., OrtonT.C., FlintO.P., and GibsonG.G. (1989). Localization and identification of cytochrome P450 in differentiating rat embryo cells in vitro and in foetal tissue in vivo by immunocytochemistry.Toxicology in Vitro3, 245–252.
38.
BrownL.P., FosterJ.R., OrtonT.C., FlintO.P., and GibsonG.G. (1989). Inducibility and functionality of rat embryonic/foetal cytochrome P450: a study of differentiating limb bud and mid-brain cells in vitro.Toxicology in Vitro3, 253–260.
39.
WiseL.D., ClarkR.L., RundellJ.O., and RobertsonR.T. (1990). Examination of a rodent limb bud micromass assay as a pre-screen for developmental toxicity.Teratology41, 341–351.
40.
KoelmanH.J.S., JongelingA.J., van ErpY.H.M., WeteringsP.J.M., KoopmansM.E., JoostenH.F., van der DobbelsteenD.J., van der AaE.M., and YihT.D. (1991). International ring validation of the in vitro micromass teratogenicity test: preliminary results of three Dutch laboratories.Teratology44, 30A.
41.
SabourinT.D., and FaulkR.T. (1987). Comparative evaluation of a short-term test for developmental effects using frog embryos. In Banbury Report 26: Developmental Toxicology: Mechanisms and Risk (ed. McLachlanJ.A., PrattR.M., MarkertC.L.), pp. 203–223. New York: Cold Spring Harbor Laboratory.
42.
DawsonD.A., FortD.J., NewellD.L., and BantleJ.A. (1989). Developmental toxicity testing with FETAX: evaluation of five compounds.Drug and Chemical Toxicology12, 67–75.
43.
BantleJ.A., FortD.J., RayburnJ.R., DeYoungD.J., and BushS.J. (1990). Further validation of FETAX: evaluation of the developmental toxicity of five known mammalian teratogens and non-teratogens.Drug and Chemical Toxicology13, 267–282.
44.
Anon. (1967). Principles for the testing of drugs for teratogenicity. Report of a WHO scientific group.WHO Technical Report Series364, 1–18.
45.
JelínekR. (1977). The chick embryotoxicity screening test (CHEST). In Methods in Prenatal Toxicology (ed. NeubertD., MerkerH.J., KwasigrochT.E.), pp. 381–386. Stuttgart: G. Thieme.
46.
JelínekR., RychterZ., and PeterkaM. (1979). Embryotoxicity assay on morphogenetic systems. In Evaluation of Embryotoxicity, Mutagenicity and Carcinogenicity Risks in New Drugs (ed. BenesovaO., RychterZ., & JelínekR.), pp. 195–205. Prague: Univerzita Karlova.
47.
JelínekR., and PeterkaM. (1981). Morphogenetic systems and in vitro techniques in teratology. In Culture Techniques, Applicability for Studies on Prenatal Differentiation and Toxicity (ed. NeubertD., MerkerH.J.), pp. 553–557. Berlin: Walter de Gruyter.
48.
MarhanO., & JelínekR. (1979). Efficiency of the embryotoxicity testing procedures. II. Comparison between the official, MEST and CHEST methods.Toxicology Letters4, 389–392.
JelínekR., PeterkaM., and RychterZ. (1985). Chick embryotoxicity screening test: 130 substances tested.Indian Journal of Experimental Biology23, 588–595.
51.
PeterkaM., JelínekR., and PavllikA. (1992). Embryotoxicity of 25 psychotropic drugs: a study using CHEST.Reproductive Toxicology6, 367–374.
52.
KuceraP., CanoE., HoneggerP., SchilterB., ZulstraA., and SchmidB. (1993). Validation of whole chick embryo cultures, whole rat embryo cultures and aggregating embryonic brain cell cultures using six pairs of coded compounds.Toxicology in Vitro7, 785–798.
53.
SadlerT.W., HortonW.E., and WarnerC.W. (1982). Whole-embryo culture: a screening technique for teratogens?Teratogenesis, Carcinogenesis and Mutagenesis2, 243–253.
54.
SchmidB.P. (1985). Teratogenicity testing of new drugs with the postimplantation embryo culture system. In Concepts in Toxicology, Volume 3 (ed. HomburgerF.), pp. 46–57. Basle: Karger.
55.
NinomiyaH., KishidaK., OhnoY., TsurumiK., & EtoK. (1993). Effects of trypan blue on rat and rabbit embryos cultured in vitro.Toxicology in Vitro7, 707–717.
56.
BechterR., TerlouwG.D.C., LeeQ.P., and JuchauM.R. (1991). Effects of QA 208–199 and its metabolite 209–668 on embryonic development in vitro after microinjection into the exocoelomic space or into the amniotic cavity of cultured rat conceptuses.Teratogenesis, Carcinogenesis and Mutagenesis11, 185–194.
57.
SadlerT.W. (1979). Culture of early somite mouse embryos during organogenesis.Journal of Embryology and Experimental Morphology49, 17–25.
58.
KlugS., LewandowskiC., and NeubertD. (1985). Modification and standardization of the culture of early postimplantation embryos for toxicological studies.Archives of Toxicology58, 84–88.
59.
KleinN.W., PlenefischJ.D., CareyS.W., FredricksonW.T., SackettG.P., BurbacherT.M., and ParkerR.M. (1982). Serum from monkeys with histories of fetal wastage causes abnormalities in cultures of whole rat embryos.Science215, 66–69.
60.
ChatotC.L., KleinN.W., PiatekJ., and PierroL.J. (1980). Successful culture of rat embryos in human serum: use in the detection of teratogens.Science207, 1471–1473.
61.
FantelA.G., GreenawayJ.C., JuchauM.R., and ShepardT.H. (1979). Teratogenic bioactivation of cyclophosphamide in vitro.Life Sciences25, 67–72.
62.
KitchinK.T., SchmidB.P., and SanyaiM.K. (1981). Teratogenicity of cyclophosphamide in a coupled microsomal activating/embryo culture system.Biochemical Pharmacology30, 59–64.
63.
ZhaoJ., KrafftN., TerlouwG.D.C., & BechterR. (1993). A model combining the whole-embryo culture with human liver S9 fraction for human teratogenic prediction.Toxicology in Vitro7, 827–831.
64.
OglesbyL.A., Ebron-McCoyM.T., LogsdonT.R., CopelandF., BeyerP.E., and KavlockR.J. (1992). In vitro embryotoxicity of a series of para-substituted phenols: structure, activity, and correlation with in vivo data.Teratology45, 11–33.
65.
BechterR., BouisP., and FischerV. (1989). Primary hepatocyte culture as an activating system for xenobiotics tested in the rat whole embryo in vitro. In Alternative Methods in Toxicology, Volume 7, In Vitro Toxicology — New Directions (ed. GoldbergA.M., PrincipeM.L.), pp. 313–326. New York: Mary Ann Liebert.
66.
SchmidB.P., TrippmacherA., and BianchiA. (1982). Teratogenicity induced in cultured rat embryos by the serum of procarbazine treated rats.Toxicology25, 53–60.
67.
van Maele-FabryG., DelhaiseF., GofflotF., and PicardJ.J. (1993). Developmental table of the early mouse postimplantation embryo.Toxicology in Vitro7, 719–725.
68.
BrownN.A., and FabroS. (1981). Quantitation of rat embryonic development in vitro: a morphological scoring system.Teratology24, 65–78.
69.
BechterR., and BrouillardJ.F. (1988). The effects of different chemical forms of a test compound on embryotoxicity, distribution and metabolism in vitro.Toxicology in Vitro2, 181–188.
70.
SchmidB.P., TrippmacherA., and BianchiA. (1983). Validation of whole-embryo culture method for in vitro teratogenicity testing. In Developments in the Science and Practice of Toxicology (ed. HayesA.W., SchnellR.C., MiyaT.S.), pp. 563–566. Amsterdam: Elsevier.
71.
CicurelL., and SchmidB.P. (1988). Postimplantation embryo culture: validation with selected compounds for teratogenicity testing.Xenobiotica18, 617–624.
72.
CicurelL., and SchmidB.P. (1988). Postimplantation embryo culture for the assessment of the teratogenic potential and potency of compounds.Experientia44, 833–840.
73.
van Maele-FabryG., PicardJ.J., AttenonP., BerthetP., DelhaiseF., GoversM.J.A.P., PetersP.W.J., PiersmaA.H., SchmidB.P., StadlerJ., VerhoefA., and VerseilC. (1991). Interlaboratory evaluation of three culture media for postimplantation rodent embryos.Reproductive Toxicology5, 417–426.
74.
GoversM.J., van Maele-FabryG., PetersP.W., PicardJ., PiersmaA.H., SchmidB.P., VerhoefA., and VerseilC. (1989). Interlaboratory validation of rodent postimplantation embryo culture as a screening test for teratogenic compounds.Teratology39, 456.
75.
PiersmaA.H., AttenonP., BechterR., GoversM.J.A.P., KrafftN., SchmidB.P., StadlerJ., VerhoefA., and VerseilC. (1995). Interlaboratory evaluation of embryotoxicity in the postimplantation rat embryo culture.Reproductive Toxicology9, 275–280.
76.
BechterR., TerlouwG.D.C., TsuchiyaM., TsuchiyaT., and KistlerA. (1992). Teratogenicity of arotinoids (retinoids) in the rat whole-embryo culture.Archives of Toxicology66, 193–197.
77.
NauH. (1990). Pharmacokinetic aspects of ire vitro teratogenicity studies: comparison to in vivo. In In Vitro Methods in Developmental Toxicology: Use in Defining Mechanisms and Risk Parameters (ed. KimmelG.L., KochharD.M.), pp. 29–43. Boca Raton, FL, USA: CRC Press.
78.
NauH. (1990). Correlation of transplacental and maternal pharmacokinetics of retinoids during organogenesis with teratogenicity.Methods in Enzymology190, 437–448.
79.
NauH., LewandowskiC., KlugS., and NeubertD. (1988). Pharmacokinetic aspects of drug effects in vitro. II. Placental transfer to the embryo and activity of some carboxylic acids structurally related to valproic acid in whole embryos in culture.Toxicology in Vitro2, 169–174.
80.
NauH., HauckR.S., and EhlersK. (1991). Valproic acid-induced neural tube defects in mouse and human: aspects of chirality, alternative drug development, pharmacokinetics and possible mechanisms.Pharmacology and Toxicology69, 310–321.
81.
KlugS., Creech KraftJ., WildiE., MerkerH-J., PersaudT.V.N., NauH., and NeubertD. (1989). Influence of 13-cis and all-trans retinoic acid on rat embryonic development in vitro: correlation with isomerisation and drug transfer to the embryo.Archives of Toxicology63, 185–192.
82.
NauH. (1993). Retinoid teratogenesis: toxi-cokinetics and structure-specificity.Archives of Toxicology, Suppl. 16, 118–127.
83.
HauckR-S., & NauH. (1992). The enantiomers of the valproic acid analogue 2-n-propyl-penti-noic acid (4-yn-VPA): asymmetric synthesis and highly stereoselective teratogenicity in mice.Pharmaceutical Research9, 850–855.
84.
HauckR-S., ElmazarM.M.A., PlumC., and NauH. (1992). The enantioselective teratogenicity of 2-n-propyl-4 pentinoic acid (4-yn-VPA) is due to stereoselective intrinsic activity and not differences in pharmacokinetics.Toxicology Letters60, 145–153.
85.
AndrewsJ.E., Ebron-McCoyM., BojicU., NauH., and KavlockR.J. (1995). Validation of an in vitro teratology system using chiral substances: stereoselective teratogenicity of 4-yn-valproic acid in cultured mouse embryos.Toxicology and Applied Pharmacology132, 310–316.